Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Docetaxel + Cisplatin + 5-FU vs Cisplatin + 5-FU in SCCHN
NCT00539630Phase 3Completed
- Sponsor
- Sanofi
- Start
- Nov 2002
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of docetaxel in squamous cell carcinoma of the head and neck (HNSCC) (2 arms), sponsored by Sanofi. Primary endpoint: Clinical Response Rate. Started Nov 2002; status: completed.
02
Drugs
docetaxel
03
Conditions
squamous cell carcinoma of the head and neck (HNSCC)
Beyond the preview
Go deeper on NCT00539630.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00539630.